INTRODUCTION
Idiopathic azoospermia/oligospermia is a complicated, multigene-related and multicausal disease (Ferlin et al., 2006) . Azoospermia factor (AZF) deletion is a dominant molecular etiology of idiopathic azoospermia/oligospermia. The non-recombining portion of the Y-chromosome (NRY) contains numerous polymorphisms, and some combination types of these normal mutations have been reported to be associated with partial AZF deletions (Yang et al., 2008) . These findings suggest that variations in NRY may create a genetic background conferring susceptibility to idiopathic azoospermia/oligospermia.
In this study, to investigate the possible association between Y-chromosome genetic background and idiopathic azoospermia/oligospermia, we analyzed the distributions of 17 Y-haplogroups and 15 AZF deletions in 193 men with normozoospermia, 193 men with azoospermia and 105 men with oligospermia. All subjects were from southwest China and were of the same geographical origin.
MATERIAL AND METHODS

Subjects
Peripheral blood samples were collected from 193 men with normozoospermia (as controls), 193 men with idiopathic azoospermia and 105 men with oligospermia, which were named Group i, Group ii, and Group iii, respectively. The selection standard of subjects was conducted in accordance with the WHO manual for the standardized investigation, diagnosis and management of the infertile male. All 491 subjects were Han People recruited from southwest China. This research was approved by the Institutional Ethics Review Boards of Sichuan University, and all the subjects signed informed consent forms.
Karyotype analysis and AZF deletion detection
Karyotyping was performed on all the subjects to eliminate samples with chromosomal abnormalities.
Genomic DNA was extracted from peripheral blood samples using DNA isolation kits (Takara, Shiga, Japan). Fifteen AZF-specific sequence-tagged sites (STSs: sY84 and sY86 for AZFa; sY127, sY134, sY121, sY124, and sY133 for AZFb; sY254, sY255, sY157, sY242, and sY277 for AZFc, and sY145, sY152, and sY153 for AZFd) were used to detect AZF deletions. The PCR products were separated by electrophoresis on a 2% agarose gel. The primer sequences and PCR conditions have been described previously (Kent-First et al., 1999) .
Y-chromosome haplogroup analysis
Seventeen highly informative NRY binary markers for East Asians were used to identify 17 haplogroups (Su et al., 1999; Jin and Su, 2000) , and the phylogenetic tree named the Y-Chromosome Consortium (YCC, 2002 ) is shown in Figure 1 . DNA segments containing the 17 markers (YAP, M15, M130, M89, M9, M45, M175, M95, M119, M120, M88, M110, M122, M7, M134, M117, and LLY22g) were amplified with the previously described primers (Karafet et al., 2008) shown in Table S1 . PCR was carried out in a 25-μL reaction volume containing 50 ng genomic DNA, 1.5 U Taq DNA polymerase (Fermentas International Inc., Burlington, Canada), 1X PCR buffer (Fermentas International Inc.), 25 mM MgCl 2 (Fermentas International Inc.), 2 mM of each dNTP (TransGen, Beijing, China), and 1 mM forward and reverse primers (Invitrogen, Beijing, China). Samples were amplified on an MG96G thermocycler (LongGene Scientific Inc., Hangzhou, China) with the following conditions: 94°C for 5 min; 32 cycles of 94°C for 30 s, 56°C for 1 min, 72°C for 1 min, and a final 10-min extension at 72°C. Fifteen binary markers (M15, M130, M89, M9, M45, M175, M95, M119, M120, M88, M110, M122, M7, M134, and M117) were detected by allele-specific primer extension (ASPE), and the segments containing these 15 markers were used for templates after treatment. The treatment reaction was carried out in a 7.5-μL reaction volume containing 5 μL PCR product, 2 U shrimp alkaline phosphatase (Fermentas International Inc.), and 10 U exonuclease I (Fermentas International Inc). Samples were treated at 37°C for 15 min and 80°C for 15 min; then, 1 μL resulting product was diluted by 1:35 times.
The PCR products of the YAP marker were separated by electrophoresis on a 2% agarose gel, and the binary marker LLY22g was detected by sequencing the PCR products. The ASPE primer sequences are shown in Table 1 
Statistical analysis
Data regarding the Y-chromosome haplogroup distribution of the experimental groups were compared with respect to the control group using an exact test. The comparison between the individual Y-haplogroup distribution of the control group and that of each experimental group was performed by the chi-square test with the SPSS V.18.0 software (SPSS Inc., Chicago, IL, USA). Table 2 . Sequence-tagged sites and azoospermia factor (AZF) deletions.
RESULTS
Karyotype analysis and AZF deletion detection
Deletions based on sY84, sY124, sY133, sY277, sY152, and sY153 were not found. Single AZFd deletion was not found in the present study.
Y-haplogroup distribution analysis
Excluding the men with AZF deletion or abnormal karyotypes, there were 193 men with normozoospermia, 159 men with azoospermia and 97 men with oligospermia in our cohort. We named these three groups as Group i, Group ii, and Group iii, respectively. Group i was considered the control group. We observed population differences in Y-haplogroups between Group i and Group ii, Group iii and Group ii + iii (P = 0.012, 0.000, and 0.000, respectively). The comparison between the individual Y-haplogroup distribution in each experimental group and that of the control group are shown in Table 3 . After Bonferroni's correction, results of the multiple significance test were as follows: 1) a significant difference in Y-haplogroup distribution was observed between Group i and Group ii in haplogroups N1* (P = 0.002), and the frequency of haplogroup N1* was higher in Group ii (10.7%) than that of Group i (2.6%); 2) a significant difference in Y-haplogroup distribution was found between Group i and Group iii in haplogroups F*, K*, P*, and O3* (P = 0.002, 0.001, 0.004, and 0.007, respectively), and the frequencies of F*, K*, and P* were higher in Group iii (9.3, 12.4, and 7.2%, respectively) than those of Group i (1.0, 2.6, and 0.5%, respectively), whereas the frequency of O3* was lower (13.4% in Group iii and 27.5% in Group i), and 3) a signifi-cant difference was also observed between Group i and Group ii + iii in haplogroups K*, N1*, and O3* (P = 0.008, 0.012, and 0.009, respectively). In contrast to Group i, the frequencies of haplogroups K* and N1* were higher in Group ii + iii (8.6 and 8.2%, respectively, in Group ii, both 2.6% in Group i), whereas the frequency of haplogroup O3* was lower (17.2% in Group ii + iii and 27.5% in Group i).
Y-haplogroups
Groups studied P Table 3 . Y-haplogroup distribution.
In the comparison of each individual Y-haplogroup, three groups were compared with the same control group respectively. Therefore, according to the formula α' = α / (k -1) (k = 4 in the present study), α' = 0.017. After Bonferroni's correction, P < 0.017 was regarded as statistically significant in this study. a P = 0.002 vs Y-haplogroup N1* in Group i.
b P = 0.002, 0.001, 0.004, and 0.007 vs Y-haplogroups F*, K*, P*, and O3* in Group i, respectively. 
DISCUSSION
AZF, located on the long arm of the Y-chromosome, was divided into 3 regions: AZFa, AZFb, and AZFc in 1996 (Vog et al., 1996) . Kent-First et al. (1999) found a 4th AZF region between AZFb and AZFc in 1999, and termed it AZFd. AZF deletions are an important etiology responsible for spermatogenic impairment (Krausz and Degl'Innocenti, 2006) . The clinical symptoms caused by AZFd deletion(s) are less serious than those caused by AZFa, AZFb, or AZFc deletion(s). According to the European Academy of Andrology/European Molecular Genetics Quality Network (EAA/EMQN) guidelines, 6 STSs (sY84 and sY86 for AZFa, sY127 and sY134 for AZFb, and sY254 and sY255 for AZFc) are recommended for the detection of AZF deletions that are termed classical AZF deletions (Simoni et al., 2004) . In this study, we added another 9 STSs (sY121, sY124, and sY133 for AZFb; sY157, sY242, and sY277 for AZFc, and sY145, sY152, and sY153 for AZFd) for AZF deletion detection, with the aim of further segregating subjects with AZF deletions. Individual AZFd deletion was not detected in any of these subjects, which might be caused by the choice of samples. The subjects we studied had idiopathic azoospermia and oligospermia, although the AZFd deletion is related to teratozoospermia and mild oligospermia (Maurer et al., 2001) .
The frequency of Y-chromosome microdeletions in infertile men ranges from 5 to 20% in worldwide surveys (Vogt, 1998; Krausz and McElreavey, 1999; Krausz et al., 2003) . In this study, the incidences observed in Group ii, Group iii and Group ii + iii were 9.33, 7.48, and 8.67%, respectively. In contrast to classical AZF deletions, the AZFc subdeletions appear to be more complicated and have regional differences. In the study conducted by Wu et al. (2007) , the b1/b3 deletion was completely absent in the studied Han-Chinese population, whereas the gr/gr subdeletion and b2/b3 subdeletion displayed higher frequencies than those of other populations.
In the human genome, the Y-chromosome contains the longest non-recombining portion (Lahn et al., 2001) . Since the polymorphisms in the NRY appeared in chronological order and had low rates of back mutation, they are suitable for identifying stable paternal lineages. The Y-chromosome haplotyping system is now the most informative haplotyping system, which has been used in evolutionary studies, forensics, medical genetics, and genealogical reconstruction (Y Chromosome Consortium, 2002) . The YCC (http://ycc.biosci.arizona.edu/) published a phylogenetic tree with 153 haplogroups identified by 243 binary markers and devised a standardized nomenclature system for it in 2002. These 153 haplogroups were distributed into 18 major clades identified by the capital letters (A-R; Y Chromosome Consortium, 2002). In 2008, the YCC reshaped the tree; the revised tree showed the relationship between 311 haplogroups based on approximately 600 binary markers, and increased the size of 2 major clades (S and T; Karafet et al., 2008) . Different Y-haplogroups may create different genetic backgrounds, which may be associated with spermatogenic impairment. Some studies reported that haplogroups K* and D* might be linked with susceptibility to spermatogenic impairment (Kuroki et al., 1999; Krausz et al., 2001) . In this study, a significant difference of Y-haplogroup distribution was observed between Group i and Group ii in haplogroup N1*, between Group i and Group iii in haplogroups F*, K*, P*, and O3*, and between Group i and Group ii + iii in haplogroups K*, N1*, and O3*. Among these 5 Y-haplogroups, the frequencies of haplogroups F*, K*, P*, and N1* were higher in experimental groups than those of the control group, whereas the frequency of haplogroup O3* was lower in experimental groups than that of the control group. These findings suggested that the Y-haplogroups F*, K*, P*, and N1* may confer Y-chromosome backgrounds that are susceptible to spermatogenic impairment. On the contrary, the Y-haplogroup O3* may create a Y-chromosome background that is less susceptible to spermatogenic impairment. The mechanism by which these Y-haplogroups function is not yet clear. We hypothesize that binary markers, which these Y-haplogroups based on, may cause some small differences in the Y-chromosome DNA structure from other Y-haplogroups. These small differences may promote some spermatogenesis-linked gene mutations or protect some spermatogenesislinked genes from mutation during DNA replication. On the other hand, these small differences could regulate the expression of some spermatogenesis-linked genes, rendering them either overexpressed or underexpressed, or even completely inhibited. However, the molecular mechanism of this theory demands further studies.
